222 related articles for article (PubMed ID: 38515032)
1. Overcoming barriers for left atrial appendage thrombus: a systematic review of left atrial appendage closure.
Zhang Z; Zhou J; Lin Q; Wang C; Huang Y; Dai Y; Zuo W; Liu N; Xiao Y; Liu Q
BMC Cardiovasc Disord; 2024 Mar; 24(1):175. PubMed ID: 38515032
[TBL] [Abstract][Full Text] [Related]
2. Should left atrial appendage closure be considered in resistant left atrial appendage thrombus cases? 'Former Foe, New Ally'.
Ates AH; Kivrak A; Karakulak UN; Coteli C; Yorgun H; Sahiner ML; Barıs Kaya E; Aytemir K
Pacing Clin Electrophysiol; 2024 Apr; 47(4):583-590. PubMed ID: 38477017
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
[TBL] [Abstract][Full Text] [Related]
4. Left atrial appendage closure in patients with left atrial appendage thrombus guided by intracardiac echocardiography.
Wang B; Chu H; Wang Z; Fu G; Yu Y; Feng M; Du X
Heart Rhythm; 2024 Jun; 21(6):812-818. PubMed ID: 38272283
[TBL] [Abstract][Full Text] [Related]
5. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure).
Kretzler L; Mues C; Wunderlich C; Langbein A; Spitzer SG; Gerk U; Schellong S; Ketteler T; Neuser H; Schwefer M; Strasser R; Ibrahim K; Schoen S; Christoph M
BMC Cardiovasc Disord; 2022 Jun; 22(1):271. PubMed ID: 35710343
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous left atrial appendage closure in the presence of thrombus: A feasibility report.
Bordignon S; Bologna F; Chen S; Konstantinou A; Tsianakas N; Tohoku S; Trolese L; Chun KJ; Schmidt B
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2858-2863. PubMed ID: 31638713
[TBL] [Abstract][Full Text] [Related]
8. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
Takeda K; Tsuboko Y; Iwasaki K
Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus.
Jin LS; Ke JY; Lin YN; Li L; Fu JY; Chen YL; Qiu YX; Li XW; Pan YQ; Li YC
Front Cardiovasc Med; 2022; 9():1071119. PubMed ID: 36505354
[TBL] [Abstract][Full Text] [Related]
10. Direct current cardioversion practices following percutaneous left atrial appendage closure.
Bhuta S; Shaaban A; Binda NC; Antaki J; Augostini RS; Kalbfleisch SJ; Savona SJ; Okabe T; Houmsse M; Afzal MR; Daoud EG; Hummel JD
J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1698-1705. PubMed ID: 37493499
[TBL] [Abstract][Full Text] [Related]
11. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
[TBL] [Abstract][Full Text] [Related]
13. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of left atrial appendage closure with or without concomitant pulmonary vein isolation:a propensity score matching analysis based on CLACBAC study.
Li X; Feng S; Ren Z; Wu J; Zhou L; Yang H; Zheng Y; Meng W; Zhang J; Su Y; Jiang Y; Xu J; Sun H; Xu Y; Zhao D; Yin X
BMC Cardiovasc Disord; 2024 Feb; 24(1):85. PubMed ID: 38310248
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter cerebral embolic protection during WATCHMAN procedure in two patients with persistent left atrial appendage thrombus: Case report with review of the literature.
Tan BE; Depta JP
Catheter Cardiovasc Interv; 2021 Feb; 97(2):365-368. PubMed ID: 32538522
[TBL] [Abstract][Full Text] [Related]
16. Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center.
Bai Y; Xue X; Duenninger E; Muenzel M; Jiang L; Keil T; Fazakas A; Yu J
Heart Vessels; 2019 Aug; 34(8):1360-1369. PubMed ID: 30820642
[TBL] [Abstract][Full Text] [Related]
17. Outcome of left atrial appendage closure using cerebral protection system for thrombosis: no patient left behind.
Limite LR; Radinovic A; Cianfanelli L; Altizio S; Peretto G; Frontera A; D'Angelo G; Baratto F; Marzi A; Ancona F; Ingallina G; Capogrosso C; Stella S; Melillo F; Agricola E; Della Bella P; Mazzone P
Pacing Clin Electrophysiol; 2022 Jan; 45(1):23-34. PubMed ID: 34841552
[TBL] [Abstract][Full Text] [Related]
18. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
[TBL] [Abstract][Full Text] [Related]
19. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
Bing S; Chen RR
Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
